FIKAX | VENAX | FIKAX / VENAX | |
Total Expense Ratio | 0.58 | 0.09 | 644% |
Annual Report Gross Expense Ratio | 0.58 | 0.09 | 644% |
Fund Existence | 7 years | 21 years | - |
Gain YTD | -3.454 | -5.040 | 69% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 897M | 8.11B | 11% |
Annual Yield % from dividends | 1.09 | 3.43 | 32% |
Returns for 1 year | -8.15 | -7.77 | 105% |
Returns for 3 years | -0.12 | -6.97 | 2% |
Returns for 5 years | 139.81 | 94.26 | 148% |
Returns for 10 years | N/A | 6.27 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MREGX | 14.72 | N/A | N/A |
BlackRock Unconstrained Equity R | |||
EMGDX | 29.30 | N/A | N/A |
Allspring Emerging Markets Equity R6 | |||
RSLDX | 70.21 | N/A | N/A |
American Funds SMALLCAP World R5E | |||
VYRDX | 15.68 | N/A | N/A |
VY® Columbia Small Cap Value II R6 | |||
RRSRX | 29.95 | -0.05 | -0.17% |
Russell Inv Global Real Estate Secs R6 |